Orphan Drugs: FDA October 2014 Approvals
The chart below identifies Orphan Drugs receiving FDA October 2014 approval as of 11/04/14 in ascending “Approval Date” order.
FDA October 2014 Orphan Products Receiving Approval
|#||Generic Name/Approval Date||Sponsor Company||Indication|
|1||Bortezomib (Velcade Injection)/ 10.08||Millennium Pharmaceuticals||Mantle Cell Lymphoma (MCL)|
|2||Nintedanib (Ofev)/ 10.15||Boehringer Ingelheim Pharmaceuticals||Idiopathic Pulmonary Fibrosis (IPF)|
|3||Pirfenidone (Esbriet)/ 10.15||InterMune||Idiopathic Pulmonary Fibrosis (IPF)|
|4||Antihemophilic factor (recombinant), porcine sequence (Obizur)/ 10.23||Baxter Healthcare||Bleeding episodes in adults with acquired Hemophilia A|
Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.